These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 6385624)

  • 1. Tumor promotion--mechanisms and implication to risk estimation.
    Yamasaki H
    Acta Pharmacol Toxicol (Copenh); 1984; 55 Suppl 2():89-106. PubMed ID: 6385624
    [No Abstract]   [Full Text] [Related]  

  • 2. Perspectives on the risk assessment for nongenotoxic carcinogens and tumor promoters.
    Perera FP
    Environ Health Perspect; 1991 Aug; 94():231-5. PubMed ID: 1954932
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Complexes of phorbol tumor promoters with protein kinase C].
    Kozhemiakina OV; Iaguzhinskiĭ LS
    Biokhimiia; 1990 Apr; 55(4):595-607. PubMed ID: 2198948
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Dual center binding of cocarcinogens of the phorbol series with a receptor].
    Kozhemiakina OV; Iaguzhinskiĭ LS
    Biokhimiia; 1989 Jan; 54(1):95-102. PubMed ID: 2719990
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intercellular communication, cell differentiation and tumour promotion.
    Yamasaki H; Enomoto T; Martel N
    IARC Sci Publ; 1984; (56):217-38. PubMed ID: 6598800
    [No Abstract]   [Full Text] [Related]  

  • 6. Results and speculations related to recent studies on mechanisms of tumor promotion.
    Weinstein IB; Horowitz AD; Mufson RA; Fisher PB; Ivanovic V; Greenebaum E
    Carcinog Compr Surv; 1982; 7():599-616. PubMed ID: 7039835
    [No Abstract]   [Full Text] [Related]  

  • 7. Development of a model to simulate the characteristics of rat liver tumor promotion by phenobarbital.
    Stevens FJ; Peraino C
    Carcinog Compr Surv; 1982; 7():105-9. PubMed ID: 7066914
    [No Abstract]   [Full Text] [Related]  

  • 8. In vitro studies on the mode of action of the phorbol esters, potent tumor promoters, part 2.
    Blumberg PM
    Crit Rev Toxicol; 1981 Jun; 8(3):199-234. PubMed ID: 7018838
    [No Abstract]   [Full Text] [Related]  

  • 9. Tumor promoters and the mechanism of tumor promotion.
    Diamond L; O'Brien TG; Baird WM
    Adv Cancer Res; 1980; 32():1-74. PubMed ID: 7008542
    [No Abstract]   [Full Text] [Related]  

  • 10. The use of in-vitro assays to study and to detect tumour promoters.
    Trosko JE; Jone C; Chang CC
    IARC Sci Publ; 1984; (56):239-52. PubMed ID: 6536597
    [No Abstract]   [Full Text] [Related]  

  • 11. Cocarcinogenesis and tumor promoters of the diterpene ester type as possible carcinogenic risk factors.
    Hecker E
    J Cancer Res Clin Oncol; 1981; 99(1-2):103-24. PubMed ID: 7251629
    [No Abstract]   [Full Text] [Related]  

  • 12. Tumor promoters in human carcinogenesis.
    Boutwell RK
    Important Adv Oncol; 1985; ():16-27. PubMed ID: 3916738
    [No Abstract]   [Full Text] [Related]  

  • 13. Tumor promotion in the liver.
    Schulte-Hermann R
    Arch Toxicol; 1985 Aug; 57(3):147-58. PubMed ID: 3904674
    [No Abstract]   [Full Text] [Related]  

  • 14. Mouse skin: a useful model system for studying the mechanism of chemical carcinogenesis.
    Boutwell RK; Verma AK; Ashendel CL; Astrup E
    Carcinog Compr Surv; 1982; 7():1-12. PubMed ID: 6802487
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phorbol ester receptors and the in vitro effects of tumor promoters.
    Blumberg PM; Delclos KB; Dunn JA; Jaken S; Leach KL; Yeh E
    Ann N Y Acad Sci; 1983; 407():303-15. PubMed ID: 6309054
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epigenetic mechanisms of liver tumor promotion.
    Williams GM
    Prog Clin Biol Res; 1990; 331():131-45; discussion 147-8. PubMed ID: 2179956
    [No Abstract]   [Full Text] [Related]  

  • 17. Quantitative aspects of drug-mediated tumour promotion in liver and its toxicological implications.
    Kunz W; Schaude G; Schwarz M; Tennekes H
    Carcinog Compr Surv; 1982; 7():111-25. PubMed ID: 7039825
    [No Abstract]   [Full Text] [Related]  

  • 18. Epidermal growth factor receptors interact with transforming growth factors produced by certain human tumor cells and are distinct from specific membrane receptors for phorbol and ingenol esters.
    Todaro GJ; De Larco JE; Shoyab M
    Carcinog Compr Surv; 1982; 7():443-62. PubMed ID: 6279294
    [No Abstract]   [Full Text] [Related]  

  • 19. Milestones in chemical carcinogenesis.
    Miller EC; Miller JA
    Semin Oncol; 1979 Dec; 6(4):445-60. PubMed ID: 394329
    [No Abstract]   [Full Text] [Related]  

  • 20. Mechanisms of tumor promotion: potential role of intercellular communication.
    Trosko JE; Chang CC; Medcalf A
    Cancer Invest; 1983; 1(6):511-26. PubMed ID: 6365277
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.